Literature DB >> 17848726

Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects.

T Lech1, J K Sadlik.   

Abstract

Determination of copper in human tissues and body fluids may be crucial in the diagnosis of Wilson's disease. In this study we evaluated urinary copper excretion and urine and blood concentration in 14 patients in whom Wilson's disease was confirmed (group A) and in 21 subjects in whom the disease was only suspected (group B). The following values (mean +/- SD) were found: 24-h urine (microg Cu/24 h), 152 +/- 135 (A) and 31.8 +/- 10.9 (B); urine (microg Cu/ml), 0.091 +/- 0.087 (A) and 0.028 +/- 0.011 (B); and blood (microg Cu/ml), 0.62 +/- 0.25 (A) and 0.72 +/- 0.09 (B). By comparison, urine copper concentration in the group of apparently healthy subjects was 0.035 +/- 0.010 (n = 50), and blood copper concentration in autopsy cases of nonpoisoned people was 0.85 +/- 0.19 (n = 73).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848726     DOI: 10.1007/s12011-007-0015-y

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  4 in total

1.  Combinatorial phenotypic screen uncovers unrecognized family of extended thiourea inhibitors with copper-dependent anti-staphylococcal activity.

Authors:  Alex G Dalecki; Aruni P Malalasekera; Kaitlyn Schaaf; Olaf Kutsch; Stefan H Bossmann; Frank Wolschendorf
Journal:  Metallomics       Date:  2016-03-03       Impact factor: 4.526

2.  Sur7 promotes plasma membrane organization and is needed for resistance to stressful conditions and to the invasive growth and virulence of Candida albicans.

Authors:  Lois M Douglas; Hong X Wang; Sabine Keppler-Ross; Neta Dean; James B Konopka
Journal:  MBio       Date:  2011-12-27       Impact factor: 7.867

3.  Biomarkers for diagnosis of Wilson's disease.

Authors:  Aidan Ryan; Sarah J Nevitt; Orla Tuohy; Paul Cook
Journal:  Cochrane Database Syst Rev       Date:  2019-11-19

Review 4.  Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications.

Authors:  Grażyna Gromadzka; Beata Tarnacka; Anna Flaga; Agata Adamczyk
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.